Rejean Guerriero

Medicine & Life Sciences

1. Pediatrics 100%
2. Status Epilepticus 73%
3. Electroencephalography 72%
4. Child 57%
5. Neurology 50%
6. Brain Injuries 42%
7. Critical Illness 40%
8. Cocaine 40%
9. Critical Care 34%
10. Seizures 32%
11. Nucleus Accumbens 26%
12. Benzodiazepines 19%
13. Nervous System Diseases 18%
14. Internship and Residency 17%
15. Sleep 14%
16. Neurologists 13%
17. Confidence Intervals 12%
18. Traumatic Brain Injury 12%
19. Nervous System 11%
20. Therapeutics 11%
21. Extracorporeal Membrane Oxygenation 11%
22. Moyamoya Disease 10%
23. Population 10%
24. Neuropsychology 10%
25. Time-to-Treatment 10%
26. Canada 10%
27. Basolateral Nuclear Complex 10%
28. Dopamine D1 Receptors 10%
29. Survivors 9%
30. Methylphenidate 9%
31. Basilar Artery 9%
32. Intensive Care Units 9%
33. Neurotransmitter Receptor 9%
34. Immediate-Early Genes 9%
35. Ventral Tegmental Area 9%
36. Epilepsy 9%
37. Optimism 9%
38. Aftercare 9%
39. Brain 9%
40. Mitogen-Activated Protein Kinase 3 9%
41. Heart Arrest 9%
42. Mitogen-Activated Protein Kinase 1 8%
43. Odds Ratio 8%
44. Amphetamine 8%
45. Workforce 8%
46. Holidays 8%
47. North America 8%
48. Vasoconstriction 8%
49. Pediatric Intensive Care Units 8%
50. Nicotine 7%